BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 14, 2012
View Archived Issues
Osteros Biomedica prepares for proof-of-concept MBC-11 study
Read More
Multiple studies confirm D-type cyclins as therapeutic targets in cancer
Read More
Adaptimmune presents gene-engineered autologous T cells for multiple myeloma
Read More
Immunomedics develops antibodies with potential in the therapeutic intervention of lymphoma
Read More
Gilead Sciences patents novel sodium channel blockers
Read More
French and U.S. researchers present novel Mdm2 inhibitors for cancer
Read More
Janssen submits NDA for canagliflozin/metformin combination
Read More
4SC reports interim data from phase I/II trial of resminostat
Read More
Milestone reached in DuoBody platform collaboration
Read More
Method devised to detect biomarker of idiopathic pulmonary fibrosis
Read More
Lamazym advances to phase III alpha-mannosidosis trial
Read More
FDA approves supplemental NDA for Rescula
Read More
Kyowa Hakko Kirin begins pivotal phase III mogamulizumab study in CTCL
Read More
BrainStorm Cell Therapeutics receives grant from Israel's Office of the Chief Scientist
Read More
Amgen set to acquire deCODE Genetics
Read More
FDA accepts for review NDA for vortioxetine
Read More
NIH-sponsored trial of AstraZeneca's TB candidate commences in South Africa
Read More
Safety of antimalarial tafenoquine evaluated in phase I study
Read More
Japanese scientists present novel agents for Fabry's disease
Read More
Matrivax Research & Development Corp. patents new pneumococcal vaccines
Read More
New orexin receptor antagonists prepared by Taisho Pharmaceutical
Read More
Bayer submits MAA to EMA for prostate cancer treatment
Read More
U.S. researchers synthesize novel autophagy inhibitors
Read More
AstraZeneca reports on OSKIRA-4 phase IIb fostamatinib study
Read More
ISIS-TTRRx receives fast track designation from FDA
Read More
Insero Health completes phase Ib study of INS-001
Read More
FDA accepts for review macitentan NDA
Read More